Yale Image Finder

Search the actual image content of 1,538,051 (and growing!) Open Access images and figures from PubMed Central.


Advanced...

Related Figures


Fig. 1 Overall survival and event-free survival...

Figure 1 Overall survival and progression-free su...

Figure 1 Overall survival and failure-free surviv...

Figure 1 Progression-free survival and overall su...

Figure 1 Observed survival curve and extrapolated...

Figure 1 Progression-free survival and overall su...

Figure 3 mREMS and survival rates

Figure 2 ER status and survival.

Fig. 1 Overall and ocular survival.

Figure 2 Survival and IP status.

Fig. 2: Kaplan–Meier curves for (a) overall survival and (b) disease-specific survival by tumour stage (radical radiotherapy and chemoradiotherapy groups only).

Image Text (High Precision): patients radiotherapy

Other Images from "Substantial Improvement in UK Cervical Cancer Survival with Chemoradiotherapy: Results of a Royal College of Radiologists’ Audit":


Fig. 1 Kaplan–Meier curves for (a) overall surv...

Fig. 2 Kaplan–Meier curves for (a) overall surv...

Fig. 3 Kaplan–Meier curves for (a) late bowel t...

[Full Text] [PDF]

Abstract

AimsTo compare survival and late complications between patients treated with chemoradiotherapy and radiotherapy for locally advanced cervix cancer.Materials and methodsA Royal College of Radiologists’ audit of patients treated with radiotherapy in UK cancer centres in 2001–2002. Survival, recurrence and late complications were assessed for patients grouped according to radical treatment received (radiotherapy, chemoradiotherapy, postoperative radiotherapy or chemoradiotherapy) and non-radical treatment. Late complication rates were assessed using the Franco-Italian glossary.ResultsData were analysed for 1243 patients from 42 UK centres. Overall 5-year survival was 56% (any radical treatment); 44% (radical radiotherapy); 55% (chemoradiotherapy) and 71% (surgery with postoperative radiotherapy). Overall survival at 5 years was 59% (stage IB), 44% (stage IIB) and 24% (stage IIIB) for women treated with radiotherapy, and 65% (stage IB), 61% (stage IIB) and 44% (stage IIIB) for those receiving chemoradiotherapy. Cox regression showed that survival was significantly better for patients receiving chemoradiotherapy (hazard ratio = 0.77, 95% confidence interval 0.60–0.98; P = 0.037) compared with those receiving radiotherapy taking age, stage, pelvic node involvement and treatment delay into account. The grade 3/4 late complication rate was 8% (radiotherapy) and 10% (chemoradiotherapy). Although complications continued to develop up to 7 years after treatment for those receiving chemoradiotherapy, there was no apparent increase in overall late complications compared with radiotherapy alone when other factors were taken into account (hazard ratio = 0.94, 95% confidence interval 0.71–1.245; P = 0.667).DiscussionThe addition of chemotherapy to radiotherapy seems to have improved survival compared with radiotherapy alone for women treated in 2001–2002, without an apparent rise in late treatment complications.


Search: Image Text (High Recall) Image Text (High Precision) Caption Abstract Title Full Text

All images and content copyright their respective owners. All else copyright ©2007-2008, Krauthammer Lab, Yale University.

Sign up for Yale Image Finder announcements:

Email: